HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoram Palti Selected Research

Antimitotic Agents

6/2022Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo.
10/2021Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.
10/2020Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
12/2017Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
12/2015Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
1/2014Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields.
7/2013Tumor treating fields: a new frontier in cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoram Palti Research Topics

Disease

20Neoplasms (Cancer)
06/2022 - 05/2004
7Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2012
4Glioma (Gliomas)
10/2018 - 06/2007
3Breast Neoplasms (Breast Cancer)
05/2010 - 06/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 06/2007
2Melanoma (Melanoma, Malignant)
01/2009 - 06/2007
1Hepatocellular Carcinoma (Hepatoma)
06/2022
1Fanconi Anemia (Fanconi's Anemia)
10/2021
1Malignant Mesothelioma
10/2021
1Colonic Neoplasms (Colon Cancer)
07/2020
1Hypersensitivity (Allergy)
05/2020
1Ovarian Neoplasms (Ovarian Cancer)
12/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014
1Lewis Lung Carcinoma
10/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2014
1Neoplasm Metastasis (Metastasis)
01/2009
1Contact Dermatitis (Eczema, Contact)
06/2007

Drug/Important Bio-Agent (IBA)

7Antimitotic AgentsIBA
06/2022 - 07/2013
4Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 01/2009
3Temozolomide (Temodar)FDA LinkGeneric
12/2017 - 12/2015
2Pemetrexed (MTA)FDA Link
10/2021 - 10/2014
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 10/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2010 - 01/2009
1Sorafenib (BAY 43-9006)FDA Link
06/2022
1PlatinumIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1Proteins (Proteins, Gene)FDA Link
10/2021
1Adenosine Triphosphate (ATP)IBA
07/2020
1CalreticulinIBA
07/2020
1Contrast MediaIBA
05/2020
1Autophagy-Related Protein 7IBA
10/2018
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2018
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2017
1Pharmaceutical PreparationsIBA
05/2010
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2010
1EmetineIBA
05/2010
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
05/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2009
1Dacarbazine (DIC)FDA LinkGeneric
01/2009
1salicylhydroxamic acid (SHAM)IBA
01/2009
1Capsules (Microcapsules)IBA
01/2009

Therapy/Procedure

8Therapeutics
10/2021 - 07/2008
7Drug Therapy (Chemotherapy)
10/2021 - 01/2009
3Electrodes (Electrode)
07/2008 - 05/2004
2Chemoradiotherapy
12/2017 - 12/2015
1Combined Modality Therapy
06/2022
1Duration of Therapy
07/2020
1Critical Care (Surgical Intensive Care)
05/2020
1Radiotherapy
12/2017
1Implanted Electrodes
06/2007